# NYC Passport #81627Y0873

Roche molecular testing assays, reagents, and consumables for the NYC Public Health Laboratory

**Posted:** October 21, 2026
**Respond By:** November 02, 2026
**Identifier:** 81627Y0873
**NAICS:** 423490, 325413, 423450

New York City DOHMH is seeking Roche supplies to support molecular testing at the NYC Public Health Laboratory.
- **Buyer:** City of New York Department of Health and Mental Hygiene (DOHMH), for the NYC Public Health Laboratory (PHL).
- **OEM:** **Roche Diagnostic Corporation** is identified as the sole manufacturer and distributor of the requested assays, reagents, and consumables for the laboratory’s existing Roche platforms.
- **Requested supplies:** Assays, reagents, and consumables for cobas 5800, cobas 6800v2, and cobas 8800v2 systems; MagNA Pure 96 nucleic-acid extraction kits; and supplies for LightCycler 96 and LightCycler PRO PCR systems. No purchase quantities or part numbers are provided. The MagNA Pure offering specifies two DNA and Viral Nucleic Acid Kits and one Cellular RNA Kit, but does not state order quantities.
- **Testing coverage:** Listed assays include HIV, hepatitis, CMV, EBV, BKV, SARS-CoV-2, respiratory pathogens, HPV, chlamydia and gonorrhea (CT/NG), and TV/MG; the notice also describes support for other targets and laboratory-developed tests.
- **Notable requirement:** Only Roche-certified service engineers may perform service activities on these systems. The procurement is intended to increase testing capacity and reduce detection times.
- **Term:** Anticipated six-year agreement; no option years or annual subscription terms are specified.

### Description

DOHMH is seeking expressions of interest for a planned six-year sole-source agreement to provide assays, reagents, and consumables used with Roche cobas® 5800, 6800v2, and 8800v2, MagNA Pure96, and LightCycler systems. The systems and supplies support molecular testing, including tests for HIV, sexually transmitted infections, bloodborne pathogens, and other targets, as well as nucleic acid extraction and laboratory-developed tests. The NYC Public Health Lab will use the equipment and kits to reduce detection time for sexually transmitted infections and increase testing capacity. The anticipated contract term is July 1, 2027 through June 30, 2033, and interested firms are invited to submit an Expression of Interest by November 2, 2026, at 2:00 PM.

[View original listing](https://passport.cityofnewyork.us/page.aspx/en/bpm/process_manage_extranet/38967)